The U.S. District Court for the Southern District of Florida recently denied Neutrogena’s motion to dismiss, finding that federal law does not preempt the plaintiff’s claims that Neutrogena deceptively marketed two sunscreen products, Ultra Sheer Body Mist SPF 30 and Beach Defense Broad Spectrum SPF Lotion 70. Dapeer v. Neutrogena Corp., No.14-22113 (S.D. Fla., order entered March 25, 2015). Neutrogena argued that plaintiff’s claims were preempted because they seek to impose labeling requirements that differ from those established by the U.S. Food and Drug Administration (FDA). The plaintiff argued that he was not seeking to change the way Neutrogena displays SPF value, but that the marketing of higher SPF ratings by charging a premium and claiming greater protection is misleading and deceptive.